Dr. Anil Julius Trindade, MD

Dr. Trindade practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Trindade's NPI, 1720132582, was assigned on January 22, 2007. Dr. Trindade graduated from Duke University School of Medicine in 2005. Dr. Trindade holds Tennessee license 59713.

Dr. Trindade's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Trindade's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Trindade is also affiliated with Vanderbilt Wilson County Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Trindade to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trindade practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Trindade's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Trindade's licenses on file in 3 states: Tennessee, Massachusetts and New York.

CMS data shows 483 Medicare services from Dr. Trindade across 10 procedure codes in 2024, for 157 Medicare patients. Medicare paid $31,627 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 157 Medicare patients who saw Dr. Trindade in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trindade's median patient age at 67, with 50% women.

In 2024, Dr. Trindade wrote 1,343 Medicare Part D claims for 178 patients. 92% of them were for generic drugs. CMS names the drug for 1,086 of them, across 28 drugs with 11 or more claims each, at $50,750 in total drug cost. In 2023, CMS named 510 claims across 19 drugs.

Dr. Trindade accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 32 papers to Dr. Trindade, published from 2013 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Lung Transplantation, Transplant Recipients and COVID-19. Dr. Trindade has published most often in Transpl Infect Dis. Dr. Trindade's most frequent co-authors are Matthew Dominic Bacchetta, MD, Hilary J. Goldberg, MD and David Brett Erasmus, MD.

Dmand AI links Dr. Trindade to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Bronchiolitis Obliterans Syndrome and Organizing Pneumonia.

CMS Open Payments shows 20 general payments to Dr. Trindade from 7 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 51% of the total. Pulmonx Corporation paid the most, $3,849. It also lists 1 research payment totaling $90 in 2025.

Dr. Trindade graduated from Duke University School of Medicine in 2005.